Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Awesome post thanks
Wow 2 times in 1 day about the same article! Get a grip! It's an informative piece on the blog site!
Yep they tried to get it to close below $1 and they ran out of steam. To many people anticipating the catalyst around the corner and snapping up the cheap shares.
Leo didn't increase the P trial locations and bring Dr. B on because he wanted to slow things down.
Sorry I'm a little slow this morning can you spell it out for me
Because they make trades off his writing. That's why he has 60k followers! Not because he is a good writer or has deep insight or analysis.
Spend some time reading the posts today and you will realize the crap he wrote wasn't thoughtful or well written. He deceives and manipulates.
And if the issue was so alarming why did fda give them the go ahead for trial?
Well said. Thank you
Dammed if you do Dammed if you don't. That's the piont of the strategy.
How about the fact that he didn't answer his questions! He did . AF didn't like or understand them but he did answer him. Remember his intention is to misguide and short and distort.
His intention is to short so he cherry picks data and creates a story. This could be done with every biotech and every trial.
The rebuttal wouldn't be enough and then there would be another story and more lies. That's the way he operates. You should know if you follow him. He was passed because the mako piece didn't work.
Think about it. Why would the great and powerful AF stoop to spending 10min writing an article about an otc company? Really why? Why did he tweet after the mako article? Because that's what shorters do! Thy create stories/scenarios and then bet against the company. He has done this to many companies. He is no better than Mako.
Adam F. Is a criminal short. He failed last week with his tweets in response to mako so now he thinks he needs to try again.
Nice close on high volume! I was a little concerned when they gapped the open.
Great article in fierce biotech about how BP is set to lose billions in sales to drugs coming off patent. "Generics set to undercut blockbusters from Merck, Novartis and Bristol-Myers"
My dad had UC and it could be very debilitating at times. Hopefully your combo therapy is working for you and hopefully B will be an alternative someday soon.
No. Ask away. Just was curious why you would ask if it was a combination therapy when it's never been mentioned in any way. It's interesting thought though.
Do you have any information that states that the trial is a combination trial?
Please do not look at sa piece. It just creates traffic and that is all they want.
It's pretty clear now. The pattern is
1. News out
2. Mako fake news
3. AF follows up
AF is complete trash and everybody can now see he is connected to mako! Complete garbage!
Looks like news is expected soon.
And what is really amazing is that you and am17 are still invested! Lmao!
I don't think the sales department counts. Good luck though
The share price doesn't go up on Nda it will go way before that. 2017 will be pivotal.
How was the Q&A session? Thanks
It wasn't a show. It was an opportunity for the company to meet with other industry executives about partnering. There is more going on here than ever before.
What a bunch of BS. He was brought in to sell the company. Just like Dr. B is here to partner P.
No she did not attend.
Again it's our riskiest candidate. Many trials which equals time money and hurdles. Oncology trials are always risky.
K has a lot of potential but it is also our riskiest candidate. Many hurdles, years and dollars before k reaches its potential.
Imagine what it would be without the 505 2 (b)!
That's a great idea for all longs to do. There was a lot of drama with this company over the years. Lot's of fud and crap spread as well.
But your piont that it was a bumpy ride and it took longer than you thought and that you should of stayed in are points that we should all remember.
Ariad has 1 drug for cml(my wife is on this drug) less than $150m worldwide sales and another drug i believe in p3. Imagine what great P results will be worth!
Please enough with the bs. Karin was there and you weren't and she just politely called you out.
Agree. It will be interesting to see what they will emphasis and if there are any updates on any other trials.
Remember the trial was designed for head and neck patients because an extremely high percentage of them develop om.